Peripheral Vascular Devices | Market Insights | Latin America (Supplemental) | 2022
While the COVID-19 pandemic will have a negative impact on the Latin American peripheral vascular device market in the short term, a large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost constraints in the region’s publicly funded healthcare systems continue to hinder adoption of premium-priced DCBs and DES and limit the pace of revenue expansion.
This report provides high-level market metrics for PV devices in Latin America, including country-level data for major countries and aggregate data for the rest of Latin America, across an 11-year period.
Related Medtech Insights Reports
Report
Transcatheter Embolization and Occlusion Devices | Market Insights | Latin America (Supplemental) | 2023
Although COVID-19 has negatively impacted the Latin American transcatheter embolization and occlusion device market, the impact of COVID-19 has been limited. The market will expand at a modest rate…
